Global Long-Acting Injectables Market Report 2021 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2027 (Based on 2020 COVID-19 Worldwide Spread)
Global Long-Acting Injectables Market Report 2021 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2027 (Based on 2020 COVID-19 Worldwide Spread)
Analysis of the Long Acting Injectables Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The Long-Acting Injectables market is expected to grow from USD X.X million in 2021 to USD X.X million by 2027, at a CAGR of X.X% during the forecast period. The global Long-Acting Injectables market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Long-Acting Injectables market. The report focuses on well-known providers in the global Long-Acting Injectables industry, market segments, competition, and the macro environment.
Under COVID-19 Outbreak, how the Long-Acting Injectables Industry will develop is also analyzed in detail in Chapter 1.7 of the report.
In Chapter 2.4, we analyzed industry trends in the context of COVID-19.
In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.
In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.
In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.
A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.
Key players in the global Long-Acting Injectables market covered in Chapter 4:
Alkermes
ForDoz Pharma
Mithra
Cambrex
Lubrizol
In Chapter 11 and 13.3, on the basis of types, the Long-Acting Injectables market from 2016 to 2027 is primarily split into:
Small and Middle Sized Molecule
Large Sized Molecule
In Chapter 12 and 13.4, on the basis of applications, the Long-Acting Injectables market from 2016 to 2027 covers:
Schizophrenia
Bipolar Disorder
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2016-2027) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Period: 2021-2027
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Long-Acting Injectables Market Share by Type (2021-2027)
1.5.2 Small and Middle Sized Molecule
1.5.3 Large Sized Molecule
1.6 Market by Application
1.6.1 Global Long-Acting Injectables Market Share by Application (2021-2027)
1.6.2 Schizophrenia
1.6.3 Bipolar Disorder
1.7 Long-Acting Injectables Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Long-Acting Injectables Industry Development
2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19
3 Value Chain of Long-Acting Injectables Market
3.1 Value Chain Status
3.2 Long-Acting Injectables Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Long-Acting Injectables
3.2.3 Labor Cost of Long-Acting Injectables
3.2.3.1 Labor Cost of Long-Acting Injectables Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19
4 Players Profiles
4.1 Alkermes
4.1.1 Alkermes Basic Information
4.1.2 Long-Acting Injectables Product Profiles, Application and Specification
4.1.3 Alkermes Long-Acting Injectables Market Performance (2016-2021)
4.1.4 Alkermes Business Overview
4.2 ForDoz Pharma
4.2.1 ForDoz Pharma Basic Information
4.2.2 Long-Acting Injectables Product Profiles, Application and Specification
4.2.3 ForDoz Pharma Long-Acting Injectables Market Performance (2016-2021)
4.2.4 ForDoz Pharma Business Overview
4.3 Mithra
4.3.1 Mithra Basic Information
4.3.2 Long-Acting Injectables Product Profiles, Application and Specification
4.3.3 Mithra Long-Acting Injectables Market Performance (2016-2021)
4.3.4 Mithra Business Overview
4.4 Cambrex
4.4.1 Cambrex Basic Information
4.4.2 Long-Acting Injectables Product Profiles, Application and Specification
4.4.3 Cambrex Long-Acting Injectables Market Performance (2016-2021)
4.4.4 Cambrex Business Overview
4.5 Lubrizol
4.5.1 Lubrizol Basic Information
4.5.2 Long-Acting Injectables Product Profiles, Application and Specification
4.5.3 Lubrizol Long-Acting Injectables Market Performance (2016-2021)
4.5.4 Lubrizol Business Overview
5 Global Long-Acting Injectables Market Analysis by Regions
5.1 Global Long-Acting Injectables Sales, Revenue and Market Share by Regions
5.1.1 Global Long-Acting Injectables Sales by Regions (2016-2021)
5.1.2 Global Long-Acting Injectables Revenue by Regions (2016-2021)
5.2 North America Long-Acting Injectables Sales and Growth Rate (2016-2021)
5.3 Europe Long-Acting Injectables Sales and Growth Rate (2016-2021)
5.4 Asia-Pacific Long-Acting Injectables Sales and Growth Rate (2016-2021)
5.5 Middle East and Africa Long-Acting Injectables Sales and Growth Rate (2016-2021)
5.6 South America Long-Acting Injectables Sales and Growth Rate (2016-2021)
6 North America Long-Acting Injectables Market Analysis by Countries
6.1 North America Long-Acting Injectables Sales, Revenue and Market Share by Countries
6.1.1 North America Long-Acting Injectables Sales by Countries (2016-2021)
6.1.2 North America Long-Acting Injectables Revenue by Countries (2016-2021)
6.1.3 North America Long-Acting Injectables Market Under COVID-19
6.2 United States Long-Acting Injectables Sales and Growth Rate (2016-2021)
6.2.1 United States Long-Acting Injectables Market Under COVID-19
6.3 Canada Long-Acting Injectables Sales and Growth Rate (2016-2021)
6.4 Mexico Long-Acting Injectables Sales and Growth Rate (2016-2021)
7 Europe Long-Acting Injectables Market Analysis by Countries
7.1 Europe Long-Acting Injectables Sales, Revenue and Market Share by Countries
7.1.1 Europe Long-Acting Injectables Sales by Countries (2016-2021)
7.1.2 Europe Long-Acting Injectables Revenue by Countries (2016-2021)
7.1.3 Europe Long-Acting Injectables Market Under COVID-19
7.2 Germany Long-Acting Injectables Sales and Growth Rate (2016-2021)
7.2.1 Germany Long-Acting Injectables Market Under COVID-19
7.3 UK Long-Acting Injectables Sales and Growth Rate (2016-2021)
7.3.1 UK Long-Acting Injectables Market Under COVID-19
7.4 France Long-Acting Injectables Sales and Growth Rate (2016-2021)
7.4.1 France Long-Acting Injectables Market Under COVID-19
7.5 Italy Long-Acting Injectables Sales and Growth Rate (2016-2021)
7.5.1 Italy Long-Acting Injectables Market Under COVID-19
7.6 Spain Long-Acting Injectables Sales and Growth Rate (2016-2021)
7.6.1 Spain Long-Acting Injectables Market Under COVID-19
7.7 Russia Long-Acting Injectables Sales and Growth Rate (2016-2021)
7.7.1 Russia Long-Acting Injectables Market Under COVID-19
8 Asia-Pacific Long-Acting Injectables Market Analysis by Countries
8.1 Asia-Pacific Long-Acting Injectables Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Long-Acting Injectables Sales by Countries (2016-2021)
8.1.2 Asia-Pacific Long-Acting Injectables Revenue by Countries (2016-2021)
8.1.3 Asia-Pacific Long-Acting Injectables Market Under COVID-19
8.2 China Long-Acting Injectables Sales and Growth Rate (2016-2021)
8.2.1 China Long-Acting Injectables Market Under COVID-19
8.3 Japan Long-Acting Injectables Sales and Growth Rate (2016-2021)
8.3.1 Japan Long-Acting Injectables Market Under COVID-19
8.4 South Korea Long-Acting Injectables Sales and Growth Rate (2016-2021)
8.4.1 South Korea Long-Acting Injectables Market Under COVID-19
8.5 Australia Long-Acting Injectables Sales and Growth Rate (2016-2021)
8.6 India Long-Acting Injectables Sales and Growth Rate (2016-2021)
8.6.1 India Long-Acting Injectables Market Under COVID-19
8.7 Southeast Asia Long-Acting Injectables Sales and Growth Rate (2016-2021)
8.7.1 Southeast Asia Long-Acting Injectables Market Under COVID-19
9 Middle East and Africa Long-Acting Injectables Market Analysis by Countries
9.1 Middle East and Africa Long-Acting Injectables Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Long-Acting Injectables Sales by Countries (2016-2021)
9.1.2 Middle East and Africa Long-Acting Injectables Revenue by Countries (2016-2021)
9.1.3 Middle East and Africa Long-Acting Injectables Market Under COVID-19
9.2 Saudi Arabia Long-Acting Injectables Sales and Growth Rate (2016-2021)
9.3 UAE Long-Acting Injectables Sales and Growth Rate (2016-2021)
9.4 Egypt Long-Acting Injectables Sales and Growth Rate (2016-2021)
9.5 Nigeria Long-Acting Injectables Sales and Growth Rate (2016-2021)
9.6 South Africa Long-Acting Injectables Sales and Growth Rate (2016-2021)
10 South America Long-Acting Injectables Market Analysis by Countries
10.1 South America Long-Acting Injectables Sales, Revenue and Market Share by Countries
10.1.1 South America Long-Acting Injectables Sales by Countries (2016-2021)
10.1.2 South America Long-Acting Injectables Revenue by Countries (2016-2021)
10.1.3 South America Long-Acting Injectables Market Under COVID-19
10.2 Brazil Long-Acting Injectables Sales and Growth Rate (2016-2021)
10.2.1 Brazil Long-Acting Injectables Market Under COVID-19
10.3 Argentina Long-Acting Injectables Sales and Growth Rate (2016-2021)
10.4 Columbia Long-Acting Injectables Sales and Growth Rate (2016-2021)
10.5 Chile Long-Acting Injectables Sales and Growth Rate (2016-2021)
11 Global Long-Acting Injectables Market Segment by Types
11.1 Global Long-Acting Injectables Sales, Revenue and Market Share by Types (2016-2021)
11.1.1 Global Long-Acting Injectables Sales and Market Share by Types (2016-2021)
11.1.2 Global Long-Acting Injectables Revenue and Market Share by Types (2016-2021)
11.2 Small and Middle Sized Molecule Sales and Price (2016-2021)
11.3 Large Sized Molecule Sales and Price (2016-2021)
12 Global Long-Acting Injectables Market Segment by Applications
12.1 Global Long-Acting Injectables Sales, Revenue and Market Share by Applications (2016-2021)
12.1.1 Global Long-Acting Injectables Sales and Market Share by Applications (2016-2021)
12.1.2 Global Long-Acting Injectables Revenue and Market Share by Applications (2016-2021)
12.2 Schizophrenia Sales, Revenue and Growth Rate (2016-2021)
12.3 Bipolar Disorder Sales, Revenue and Growth Rate (2016-2021)
13 Long-Acting Injectables Market Forecast by Regions (2021-2027)
13.1 Global Long-Acting Injectables Sales, Revenue and Growth Rate (2021-2027)
13.2 Long-Acting Injectables Market Forecast by Regions (2021-2027)
13.2.1 North America Long-Acting Injectables Market Forecast (2021-2027)
13.2.2 Europe Long-Acting Injectables Market Forecast (2021-2027)
13.2.3 Asia-Pacific Long-Acting Injectables Market Forecast (2021-2027)
13.2.4 Middle East and Africa Long-Acting Injectables Market Forecast (2021-2027)
13.2.5 South America Long-Acting Injectables Market Forecast (2021-2027)
13.3 Long-Acting Injectables Market Forecast by Types (2021-2027)
13.4 Long-Acting Injectables Market Forecast by Applications (2021-2027)
13.5 Long-Acting Injectables Market Forecast Under COVID-19
14 Appendix
14.1 Methodology
14.2 Research Data Source
List of Tables and Figures
Table Global Long-Acting Injectables Market Size Growth Rate by Type (2021-2027)
Figure Global Long-Acting Injectables Market Share by Type in 2020 & 2026
Figure Small and Middle Sized Molecule Features
Figure Large Sized Molecule Features
Table Global Long-Acting Injectables Market Size Growth by Application (2021-2027)
Figure Global Long-Acting Injectables Market Share by Application in 2020 & 2026
Figure Schizophrenia Description
Figure Bipolar Disorder Description
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Long-Acting Injectables Industry Development
Table SWOT Analysis
Figure Porter's Five Forces Analysis
Figure Global Long-Acting Injectables Market Size and Growth Rate 2016-2027
Table Industry News
Table Industry Policies
Figure Value Chain Status of Long-Acting Injectables
Figure Production Process of Long-Acting Injectables
Figure Manufacturing Cost Structure of Long-Acting Injectables
Figure Major Company Analysis (by Business Distribution Base, by Product Type)
Table Downstream Major Customer Analysis (by Region)
Table Alkermes Profile
Table Alkermes Production, Value, Price, Gross Margin 2016-2021
Table ForDoz Pharma Profile
Table ForDoz Pharma Production, Value, Price, Gross Margin 2016-2021
Table Mithra Profile
Table Mithra Production, Value, Price, Gross Margin 2016-2021
Table Cambrex Profile
Table Cambrex Production, Value, Price, Gross Margin 2016-2021
Table Lubrizol Profile
Table Lubrizol Production, Value, Price, Gross Margin 2016-2021
Figure Global Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure Global Long-Acting Injectables Revenue ($) and Growth (2016-2021)
Table Global Long-Acting Injectables Sales by Regions (2016-2021)
Table Global Long-Acting Injectables Sales Market Share by Regions (2016-2021)
Table Global Long-Acting Injectables Revenue ($) by Regions (2016-2021)
Table Global Long-Acting Injectables Revenue Market Share by Regions (2016-2021)
Table Global Long-Acting Injectables Revenue Market Share by Regions in 2016
Table Global Long-Acting Injectables Revenue Market Share by Regions in 2020
Figure North America Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure Europe Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure Asia-Pacific Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure Middle East and Africa Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure South America Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure North America Long-Acting Injectables Revenue ($) and Growth (2016-2021)
Table North America Long-Acting Injectables Sales by Countries (2016-2021)
Table North America Long-Acting Injectables Sales Market Share by Countries (2016-2021)
Figure North America Long-Acting Injectables Sales Market Share by Countries in 2016
Figure United States Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure Canada Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure Mexico Long-Acting Injectables Sales and Growth (2016-2021)
Figure Europe Long-Acting Injectables Revenue ($) Growth (2016-2021)
Table Europe Long-Acting Injectables Sales by Countries (2016-2021)
Table Europe Long-Acting Injectables Sales Market Share by Countries (2016-2021)
Figure Germany Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure UK Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure France Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure Italy Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure Spain Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure Russia Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure Asia-Pacific Long-Acting Injectables Revenue ($) and Growth (2016-2021)
Table Asia-Pacific Long-Acting Injectables Sales by Countries (2016-2021)
Table Asia-Pacific Long-Acting Injectables Sales Market Share by Countries (2016-2021)
Figure China Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure Japan Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure South Korea Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure Australia Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure India Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure Southeast Asia Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure Middle East and Africa Long-Acting Injectables Revenue ($) and Growth (2016-2021)
Table Middle East and Africa Long-Acting Injectables Sales by Countries (2016-2021)
Table Middle East and Africa Long-Acting Injectables Sales Market Share by Countries (2016-2021)
Figure Saudi Arabia Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure UAE Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure Egypt Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure Nigeria Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure South Africa Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure South America Long-Acting Injectables Revenue ($) and Growth (2016-2021)
Figure Brazil Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure Argentina Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure Columbia Long-Acting Injectables Sales and Growth Rate (2016-2021)
Figure Chile Long-Acting Injectables Sales and Growth Rate (2016-2021)
Table Global Long-Acting Injectables Sales by Types (2016-2021)
Table Global Long-Acting Injectables Revenue ($) by Types (2016-2021)
Figure Global Small and Middle Sized Molecule Sales and Growth Rate (2016-2021)
Figure Global Small and Middle Sized Molecule Price (2016-2021)
Figure Global Large Sized Molecule Sales and Growth Rate (2016-2021)
Figure Global Large Sized Molecule Price (2016-2021)
Table Global Long-Acting Injectables Sales by Applications (2016-2021)
Table Global Long-Acting Injectables Sales Share by Applications (2016-2021)
Figure Global Schizophrenia Sales and Growth Rate (2016-2021)
Figure Global Schizophrenia Revenue and Growth Rate (2016-2021)
Figure Global Bipolar Disorder Sales and Growth Rate (2016-2021)
Figure Global Bipolar Disorder Revenue and Growth Rate (2016-2021)
Figure Global Long-Acting Injectables Sales and Growth Rate (2021-2027)
Figure Global Long-Acting Injectables Revenue ($) and Growth Rate (2021-2027)
Table Global Long-Acting Injectables Sales Forecast by Regions (2021-2027)
Table Global Long-Acting Injectables Revenue Forecast by Regions (2021-2027)
Figure North America Long-Acting Injectables Sales Forecast (2021-2027)
Figure North America Long-Acting Injectables Revenue Forecast (2021-2027)
Figure Europe Long-Acting Injectables Sales Forecast (2021-2027)
Figure Europe Long-Acting Injectables Revenue Forecast (2021-2027)
Figure Asia-Pacific Long-Acting Injectables Sales Forecast (2021-2027)
Figure Asia-Pacific Long-Acting Injectables Revenue Forecast (2021-2027)
Figure Middle East and Africa Long-Acting Injectables Sales Forecast (2021-2027)
Figure Middle East and Africa Long-Acting Injectables Revenue Forecast (2021-2027)
Figure South America Long-Acting Injectables Sales Forecast (2021-2027)
Figure South America Long-Acting Injectables Revenue Forecast (2021-2027)
Table Global Long-Acting Injectables Sales Forecast by Types (2021-2027)
Table Global Long-Acting Injectables Sales Market Share Forecast by Types (2021-2027)
Table Global Long-Acting Injectables Revenue Market Share Forecast by Types (2021-2027)
Table Global Long-Acting Injectables Sales Market Share Forecast by Applications (2021-2027)
Table Global Long-Acting Injectables Revenue Forecast by Applications (2021-2027)
Table Global Long-Acting Injectables Revenue Market Share Forecast by Applications (2021-2027)
Research Methodology:
Long Acting Injectables Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|